Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Ultrahypofractionated radiotherapy yields non-inferior 10-year survival outcomes compared to conventional treatment in ...

Prostate cancer has been of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

Adding metastasis-directed therapy (MDT) to standard of care was tied to improvements in several survival endpoints in oligometastatic prostate cancer, a recent analysis suggests.

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

"We found that preexisting depression was associated with a 2.5-fold increase in mortality risk for patients with PCa, highlighting its role in exacerbating disease progression and worsening survival.

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

A significant legislative step has been taken in Alabama to combat prostate cancer. Senate Bill 19, which aims to eliminate ...

“For example, a pro of the PSA test is that it can lead to early detection of prostate cancer, and a con is that it can sometimes lead to anxiety or overdiagnosis, which means detecting a prostate ...

But an association with improved overall survival failed to reach statistical significance ...